相关实验视频
Updated: Jul 26, 2025

10:03
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
25.9K
黄类药物可以改善2型糖尿病及其并发症:一篇综述
Xinrui Yi1, Mosi Dong1, Naifei Guo1
1College of Traditional Chinese Medicine, Liaoning University of Traditional Chinese Medicine, Shenyang, China.
Frontiers in nutrition
|June 16, 2023
概括
黄酸,天然植物化合物,在治疗2型糖尿病及其并发症方面表现有前途. 研究表明,它们提供了比当前药物更安全,更有效的益处.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 营养科学 营养科学
背景情况:
- 全球范围内,2型糖尿病 (T2DM) 的患病率正在上升.
- 目前的T2DM药物有相关的不良影响.
- 自然产品为安全有效的血糖降低提供了潜力.
研究的目的:
- 审查黄类药物在治疗T2DM中的潜在益处.
- 探索黄素在缓解T2DM并发症中的作用.
- 为开发基于黄类的新型低血糖药物奠定基础.
主要方法:
- 关于黄素和T2DM的科学研究的文献综述.
- 对黄类药物的生物活性进行分析.
- 检查黄类药物影响T2DM及其并发症的机制.
主要成果:
- 黄类药物具有多种生物活性,包括低血糖,降脂,抗氧化和抗炎作用.
- 天然黄类药物在改善T2DM及其并发症方面表现出有效性.
- 关键机制包括抗氧化和抗炎作用,以及调节葡萄糖和脂质代谢.
结论:
- 黄类药物代表了对T2DM的有前途的自然治疗策略.
- 对黄类药物的进一步研究可能会导致开发新的低血糖药物.
- 黄类药物为T2DM管理提供了潜在的替代或辅助疗法.
相关概念视频
Diabetes: Symptoms, Diagnosis, and Complications
605
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
605
Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Diabetes Mellitus: Type 2 and Gestational
2.6K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.6K
Diabetes: Management and Pharmacotherapy
319
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
319
Pathophysiology of Diabetes
1.0K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.0K
Oral Hypoglycemic Agents: Biguanides and Glitazones
240
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
240

